Abstract
Macroautophagy (hereafter referred as to autophagy) is a vacuolar lysosomal degradative pathway for cytoplasmic macromolecules and organelles. There is growing evidence that autophagy is controlled by tumor-regulating molecules, and that it is downregulated during the early stages of tumorigenesis. Nevertheless, the relationship between autophagy and tumor progression seems to be complex, since in response to various stress situations, cancer cells are able to trigger autophagy either as a survival mechanism or conversely as a mechanism leading to cell death. Therefore, depending on the context, autophagy may trigger opposite outcomes in cancer cell fate. These two aspects of autophagy should be further taken into account in view of its possible modulation for cancer treatment.
Keywords: Autophagy, tumor, cancer therapy, apoptosis, cell death, cell survival
Current Cancer Therapy Reviews
Title: Macroautophagy as a Target of Cancer Therapy
Volume: 3 Issue: 3
Author(s): Severine Lorin, Patrice Codogno and Mojgan Djavaheri-Mergny
Affiliation:
Keywords: Autophagy, tumor, cancer therapy, apoptosis, cell death, cell survival
Abstract: Macroautophagy (hereafter referred as to autophagy) is a vacuolar lysosomal degradative pathway for cytoplasmic macromolecules and organelles. There is growing evidence that autophagy is controlled by tumor-regulating molecules, and that it is downregulated during the early stages of tumorigenesis. Nevertheless, the relationship between autophagy and tumor progression seems to be complex, since in response to various stress situations, cancer cells are able to trigger autophagy either as a survival mechanism or conversely as a mechanism leading to cell death. Therefore, depending on the context, autophagy may trigger opposite outcomes in cancer cell fate. These two aspects of autophagy should be further taken into account in view of its possible modulation for cancer treatment.
Export Options
About this article
Cite this article as:
Severine Lorin , Patrice Codogno and Mojgan Djavaheri-Mergny , Macroautophagy as a Target of Cancer Therapy, Current Cancer Therapy Reviews 2007; 3 (3) . https://dx.doi.org/10.2174/157339407781368369
DOI https://dx.doi.org/10.2174/157339407781368369 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Comprehensive Review on miR-200c, A Promising Cancer Biomarker with Therapeutic Potential
Current Drug Targets Synthesis and Anticancer Activity of 2-Aryl-6-diethylaminoquinazolinone Derivatives
Letters in Drug Design & Discovery Perspectives for Novel Mixed Diruthenium-Organic Drugs as Metallopharmaceuticals in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Signal Transduction and Photodynamic Therapy
Current Signal Transduction Therapy Potential Pathways for CNS Drug Delivery Across the Blood-Cerebrospinal Fluid Barrier
Current Pharmaceutical Design Adolescents Attitudes Toward Vaccinations: A Systematic Review
Current Pediatric Reviews Melatonin in the Biliary Tract and Liver: Health Implications
Current Pharmaceutical Design Methionine Aminopeptidases as Potential Targets for Treatment of Gastrointestinal Cancers and other Tumors
Current Drug Targets Removing Protein Aggregates: The Role of Proteolysis in Neurodegeneration
Current Medicinal Chemistry Facile Eco-compactable Design for the Synthesis and Characterization of Silver Nanoparticles
Nanoscience & Nanotechnology-Asia Edible Transgenic Plant Vaccines for Different Diseases
Current Pharmaceutical Biotechnology Targeting Indoleamine 2,3-dioxygenase (IDO) to Counteract Tumour- Induced ImmuneDysfunction: From Biochemistry to Clinical Development
Endocrine, Metabolic & Immune Disorders - Drug Targets Different Aspects of Head and Neck Squamous Cell Carcinoma: Cancer Stem Cells, their Niche and Targeted Therapy
Current Stem Cell Research & Therapy miRNAs in the Biology of Cancers and Viral Infections
Current Medicinal Chemistry The MCM Complex: Its Role in DNA Replication and Implications for Cancer Therapy
Current Cancer Drug Targets Quality Assessment of Diagnostic Methods Employed for Suspected Lung Cancer
Current Respiratory Medicine Reviews Treatment Directed to Signalling Molecules in Patients with Advanced Differentiated Thyroid Cancer
Anti-Cancer Agents in Medicinal Chemistry Tubulin-Targeting Agents in Hybrid Drugs
Current Medicinal Chemistry Chlorella vulgaris Induces Apoptosis of Human Non-Small Cell Lung Carcinoma (NSCLC) Cells
Medicinal Chemistry Structure-Based Docking Studies of GLUT4 Towards Exploring Selected Phytochemicals from Solanum xanthocarpum as a Therapeutic Target for the Treatment of Cancer
Current Drug Discovery Technologies